Intercept Pharmaceuticals, Inc.: accounts_payable
| Value | {"amount": 17598000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Intercept Pharmaceuticals, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/97d8db7f-a326-4cde-ab67-a77f14d5b63b
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-011857 · Open the official SEC filing →Retrieved: 2026-08-19T12:06:47.985899+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001270073/accounts-payable/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/97d8db7f-a326-4cde-ab67-a77f14d5b63b
History
- supersedes {"amount": 18132000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001558370-22-002666)